Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021
dc.contributor.author | Danpanichkul P. | |
dc.contributor.author | Duangsonk K. | |
dc.contributor.author | Tham E.K.J. | |
dc.contributor.author | Tothanarungroj P. | |
dc.contributor.author | Auttapracha T. | |
dc.contributor.author | Prasitsumrit V. | |
dc.contributor.author | Sim B. | |
dc.contributor.author | Tung D. | |
dc.contributor.author | Barba R. | |
dc.contributor.author | Wong R.J. | |
dc.contributor.author | Leggio L. | |
dc.contributor.author | Yang J.D. | |
dc.contributor.author | Chen V.L. | |
dc.contributor.author | Noureddin M. | |
dc.contributor.author | Díaz L.A. | |
dc.contributor.author | Arab J.P. | |
dc.contributor.author | Wijarnpreecha K. | |
dc.contributor.author | Liangpunsakul S. | |
dc.contributor.correspondence | Danpanichkul P. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-12-26T18:37:25Z | |
dc.date.available | 2024-12-26T18:37:25Z | |
dc.date.issued | 2024-01-01 | |
dc.description.abstract | Background: To investigate the trends in alcohol-associated liver disease (ALD), liver cancer from alcohol, and alcohol use disorder (AUD) burden among older adults in the United States (US). Methods: We gathered the ALD, liver cancer from alcohol, and AUD prevalence, mortality, and age-standardized rates (ASRs) from the Global Burden of Disease (GBD) Study 2021 between 2010 and 2021. We estimated the annual percent change (APC) with confidence intervals (CIs) for the burden of ALD, liver cancer from alcohol, and AUD in older adults (>70 years) in the United States. The findings were contrasted with global estimates and categorized by sex and state. Results: In 2021, there were approximately 512,340 cases of AUD, 56,990 cases of ALD, and 4490 cases of primary liver cancer from alcohol among older adults in the United States. In contrast to declining ASRs of prevalence and mortality in the global burden, these parameters were increased in older adults in the United States. From 2000 to 2021, prevalence from AUD (APC: 0.54%, 95% CI 0.43% to 0.65%), ALD (APC + 0.54%, 95% CI 0.22% to 0.86%), and primary liver cancer from alcohol (APC 2.93%, 95% CI 2.76% to 3.11%) increased. Forty states in the United States exhibited a rise in the prevalence rates of ALD in older adults. Conclusion: Our findings highlighted the increased prevalence and mortality of AUD, ALD, and primary liver cancer from alcohol among older adults in the United Sates, contrasting with the decline in global trends. Public health strategies on ALD, AUD, and primary liver cancer from alcohol, which targets older adults, are urgently needed. | |
dc.identifier.citation | Alcohol, Clinical and Experimental Research (2024) | |
dc.identifier.doi | 10.1111/acer.15516 | |
dc.identifier.eissn | 29937175 | |
dc.identifier.scopus | 2-s2.0-85212500525 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/102531 | |
dc.rights.holder | SCOPUS | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Medicine | |
dc.title | Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021 | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85212500525&origin=inward | |
oaire.citation.title | Alcohol, Clinical and Experimental Research | |
oairecerif.author.affiliation | Siriraj Hospital | |
oairecerif.author.affiliation | National University Health System | |
oairecerif.author.affiliation | Richard L. Roudebush VAMC | |
oairecerif.author.affiliation | Escuela de Medicina | |
oairecerif.author.affiliation | TTUHSC School of Medicine | |
oairecerif.author.affiliation | University of Michigan Medical School | |
oairecerif.author.affiliation | Stanford University School of Medicine | |
oairecerif.author.affiliation | Faculty of Medicine, Chiang Mai University | |
oairecerif.author.affiliation | University of California, San Diego | |
oairecerif.author.affiliation | VA Palo Alto Health Care System | |
oairecerif.author.affiliation | NUS Yong Loo Lin School of Medicine | |
oairecerif.author.affiliation | Indiana University School of Medicine | |
oairecerif.author.affiliation | National Institute on Drug Abuse (NIDA) | |
oairecerif.author.affiliation | Cedars-Sinai Medical Center | |
oairecerif.author.affiliation | Houston Methodist Hospital | |
oairecerif.author.affiliation | VCU School of Medicine | |
oairecerif.author.affiliation | University of Arizona College of Medicine – Phoenix | |
oairecerif.author.affiliation | Banner - University Medical Center Phoenix | |
oairecerif.author.affiliation | Observatorio Multicéntrico de Enfermedades Gastrointestinales (OMEGA) |